MedTrace Logo

Study of DNA in Blood Samples From Patients With Neuroblastoma

NCT00898391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 329

Last updated 2016-05-18

No results posted yet for this study

Summary

This research trial studies is deoxyribonucleic acid (DNA) in blood samples from patients with neuroblastoma. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

Conditions

  • Disseminated Neuroblastoma
  • Localized Resectable Neuroblastoma
  • Localized Unresectable Neuroblastoma
  • Recurrent Neuroblastoma
  • Regional Neuroblastoma
  • Stage 4S Neuroblastoma

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

GENETIC

polymerase chain reaction

Correlative studies

GENETIC

polyacrylamide gel electrophoresis

Correlative studies

GENETIC

DNA analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Michael Hogarty, MD · Children's Oncology Group

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898391 on ClinicalTrials.gov